211 related articles for article (PubMed ID: 15882470)
1. Use of re-randomized data in meta-analysis.
Hozo I; Djulbegovic B; Clark O; Lyman GH
BMC Med Res Methodol; 2005 May; 5():17. PubMed ID: 15882470
[TBL] [Abstract][Full Text] [Related]
2. Robustness assessments are needed to reduce bias in meta-analyses that include zero-event randomized trials.
Keus F; Wetterslev J; Gluud C; Gooszen HG; van Laarhoven CJ
Am J Gastroenterol; 2009 Mar; 104(3):546-51. PubMed ID: 19262513
[TBL] [Abstract][Full Text] [Related]
3. Study inclusion criteria and presentation of results in a meta-analysis of granulocyte colony-stimulating factor for prevention of febrile neutropenia.
Lathia N; Isogai PK; Cheung MC; Mittmann N
J Clin Oncol; 2010 Dec; 28(36):e762-3; author reply e764. PubMed ID: 21079143
[No Abstract] [Full Text] [Related]
4. A note on variance estimation in random effects meta-regression.
Sidik K; Jonkman JN
J Biopharm Stat; 2005; 15(5):823-38. PubMed ID: 16078388
[TBL] [Abstract][Full Text] [Related]
5. Ratio of means for analyzing continuous outcomes in meta-analysis performed as well as mean difference methods.
Friedrich JO; Adhikari NK; Beyene J
J Clin Epidemiol; 2011 May; 64(5):556-64. PubMed ID: 21447428
[TBL] [Abstract][Full Text] [Related]
6. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 6. Systematic reviews and meta-analyses of observational studies.
Manchikanti L; Datta S; Smith HS; Hirsch JA
Pain Physician; 2009; 12(5):819-50. PubMed ID: 19787009
[TBL] [Abstract][Full Text] [Related]
7. Colony-stimulating factors for chemotherapy-induced febrile neutropenia: a meta-analysis of randomized controlled trials.
Clark OA; Lyman GH; Castro AA; Clark LG; Djulbegovic B
J Clin Oncol; 2005 Jun; 23(18):4198-214. PubMed ID: 15961767
[TBL] [Abstract][Full Text] [Related]
8. Deriving treatment recommendations from evidence within randomized trials. The role and limitation of meta-analysis.
Freemantle N; Mason J; Eccles M
Int J Technol Assess Health Care; 1999; 15(2):304-15. PubMed ID: 10507190
[TBL] [Abstract][Full Text] [Related]
9. Borrowing strength from external trials in a meta-analysis.
Higgins JP; Whitehead A
Stat Med; 1996 Dec; 15(24):2733-49. PubMed ID: 8981683
[TBL] [Abstract][Full Text] [Related]
10. Specification of covariance structure in longitudinal data analysis for randomized clinical trials.
Lu K; Mehrotra DV
Stat Med; 2010 Feb; 29(4):474-88. PubMed ID: 20020423
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of individual patient data versus aggregate data from longitudinal clinical trials.
Jones AP; Riley RD; Williamson PR; Whitehead A
Clin Trials; 2009 Feb; 6(1):16-27. PubMed ID: 19254930
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of repeated measures study designs.
Peters JL; Mengersen KL
J Eval Clin Pract; 2008 Oct; 14(5):941-50. PubMed ID: 19018929
[TBL] [Abstract][Full Text] [Related]
13. Adjusting for observable selection bias in block randomized trials.
Ivanova A; Barrier RC; Berger VW
Stat Med; 2005 May; 24(10):1537-46. PubMed ID: 15723426
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor decrease febrile neutropenia after chemotherapy in children with cancer: a meta-analysis of randomized controlled trials.
Sung L; Nathan PC; Lange B; Beyene J; Buchanan GR
J Clin Oncol; 2004 Aug; 22(16):3350-6. PubMed ID: 15310780
[TBL] [Abstract][Full Text] [Related]
15. A note on dealing with missing standard errors in meta-analyses of continuous outcome measures in WinBUGS.
Stevens JW
Pharm Stat; 2011; 10(4):374-8. PubMed ID: 21394888
[TBL] [Abstract][Full Text] [Related]
16. Discrepancies between meta-analyses and subsequent large randomized, controlled trials.
LeLorier J; Grégoire G; Benhaddad A; Lapierre J; Derderian F
N Engl J Med; 1997 Aug; 337(8):536-42. PubMed ID: 9262498
[TBL] [Abstract][Full Text] [Related]
17. Methodological issues of randomized controlled trials for the evaluation of reproductive health interventions.
Villar J; Carroli G
Prev Med; 1996; 25(3):365-75. PubMed ID: 8781015
[TBL] [Abstract][Full Text] [Related]
18. [Colony stimulating factors in chemotherapy induced neutropenic fever].
Sanz Rubiales A; García Alvarez G; Centeno Cortés C; Martín Ortega Y; Del Valle Rivero AL; Nieto Sanz J
An Med Interna; 1998 Feb; 15(2):100-4. PubMed ID: 9542208
[TBL] [Abstract][Full Text] [Related]
19. The fallacy of enrolling only high-risk subjects in cancer prevention trials: is there a "free lunch"?
Baker SG; Kramer BS; Corle D
BMC Med Res Methodol; 2004 Oct; 4():24. PubMed ID: 15461821
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of continuous outcomes combining individual patient data and aggregate data.
Riley RD; Lambert PC; Staessen JA; Wang J; Gueyffier F; Thijs L; Boutitie F
Stat Med; 2008 May; 27(11):1870-93. PubMed ID: 18069721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
